SS-31

10mg Vial

S.S. 31is an investigational mitochondria-targeted tetrapeptide engineered to stabilize inner mitochondrial membrane cardiolipin, reduce reactive oxygen species, and preserve ATP generation, making it a powerful tool for researchers probing cellular energy failure and oxidative stress–driven pathology. By selectively accumulating within mitochondria and modulating mitochondrial permeability transition, SS-31 has demonstrated the capacity in preclinical and early clinical studies to improve bioenergetics, attenuate inflammation and fibrosis, and protect tissues ranging from myocardium and kidney to neural and retinal structures under ischemic or metabolic stress. Offered strictly for controlled research use, SS-31 enables investigators to interrogate how precise cardiolipin stabilization and ROS control can translate into improved cellular resilience, with applications spanning aging biology, cardiometabolic disease, neurodegeneration, and organ-protection models.